Genetic variations of three important antioxidative enzymes SOD2, CAT, and GPX1 in nonalcoholic steatohepatitis.

J Chin Med Assoc

Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.

Published: January 2021

AI Article Synopsis

  • The study investigates the relationship between genetic variants of antioxidant enzymes SOD2 and CAT and the risk of developing nonalcoholic steatohepatitis (NASH), a liver disease linked to oxidative stress.
  • Researchers analyzed DNA from 126 individuals with NASH, 56 with nonalcoholic fatty liver (NAFL), and 153 healthy controls, finding genetic variants significantly associated with NASH in the SOD2 and CAT genes.
  • The presence of certain variants in these genes was linked to a higher risk of NASH, suggesting these genetic markers could help identify individuals at risk and potentially guide antioxidant treatment strategies.

Article Abstract

Background: Nonalcoholic steatohepatitis (NASH) is closely related to reactive oxygen species (ROS). Superoxide anion radicals, the main product of ROS, can be reduced by manganese superoxide dismutase (SOD2) to hydrogen peroxide, which is further reduced by catalase (CAT) and glutathione peroxidase (GPX) to water. We aimed to investigate the association between the most important genetic variants of SOD2, CAT, and GPX1 and susceptibility to NASH.

Methods: A total of 126 adults with liver tissue-verified NASH, 56 patients with liver tissue-verified nonalcoholic fatty liver (NAFL), and 153 healthy controls were enrolled. Their DNA profiles were retrieved for genotype assessment of SOD2 47T>C (rs4880), CAT -262C>T (rs1001179), and GPX1 593C>T (rs1050450) variation.

Results: There were statistical differences between the SOD2 and CAT genotypes across the NASH, NAFL, and control groups, but not GPX1. The NASH group had a significantly higher frequency of subjects with SOD2 C allele (38.8%) compared with the NASL group (25.0%) and the controls (22.9%, p = 0.010). Similarly, the NASH group had a significantly higher percentage of subjects with CAT T allele (23.0%) compared with the NAFL group (10.7%) and the controls (7.2%, p = 0.001). For subjects with both the SOD2 C allele and CAT T allele, 88.2% were in the NASH group. After adjusting for confounders, the CAT mutant T allele and SOD2 mutant C allele were still the highest independent risk factors for NASH (odds ratio [OR] 3.10 and 2.36, respectively). In addition, there was a synergistic effect for those two alleles and the occurrence of NASH with an adjusted OR of 8.57 (p = 0.030).

Conclusion: The genetic variations of CAT and SOD2 may increase the risk of NASH, which may aid in the screening of patients who are at high risk of NASH, and offer a potential anti-oxidant targeting route for the treatment of NASH.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCMA.0000000000000437DOI Listing

Publication Analysis

Top Keywords

sod2 cat
12
nash group
12
nash
11
sod2
9
cat
9
genetic variations
8
cat gpx1
8
nonalcoholic steatohepatitis
8
liver tissue-verified
8
group higher
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!